Earl Fender

Earl Fender has a long and successful history in the medical device industry. Earl is currently an advisor at Vensana Capital, but they have also served as the President and CEO of Vertiflex, Inc. and as Worldwide President of DePuy Spine. Under Earl's leadership, Vertiflex successfully completed FDA’s largest, most robust device clinical trial for lumbar spinal stenosis, resulting in Premarket Approval (PMA) of the Superion Indirect Decompression System. The company then commercialized Superion and experienced a period of expansive and rapid growth. Vertiflex was later acquired by Boston Scientific in June 2019.

At DePuy Spine, Earl led the company to become the world’s second largest spinal implant company. Earl also oversaw the expansion of the Synthes USA sales force and accelerated growth during their time as Vice President & General Manager. Prior to joining Vertiflex, Earl served as Vice President & General Manager of Osiris Therapeutics where they led the Osiris Osteocel business from scale-up to become one of the world’s leading commercialized cellular technologies. Earl's wealth of experience and success in the medical device industry make him a valuable asset to any company.

Earl Fender attended Harvard Business School for their Program for Management Development. Earl also holds a Bachelor of Arts from Thiel College in the field of Business Administration and Management, General.